Back

Angioscopic differences in quality and quantity of neointima in patients experiencing an acute coronary syndrome treated with bare metal, first-, second-, and third generation drug-eluting stents

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Invasive Imaging Imaging of Coronary Artery Disease ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Takero Matsuura

Kindai University, Osaka (Japan)

10 More presentations in this session

Presentation thumbnail
Difference of vascular healing after percutaneous coronary intervention between 4 kinds of new generation drug-eluting stents: an optical coherence tomography analysis
Doctor Y. Matsuhiro (Osaka, JP)
Abstract
Presentation thumbnail
Angioscopic comparison between polymer-free biolimus A9-coated stent and durable polymer drug-eluting stent 10 months after the implantation
Doctor T. Tsujimura (Amagasaki, JP)
Abstract Slides
Presentation thumbnail
Cholesterol crystals in superficial plaque layer detected by optical coherence tomography as a new morphological feature for plaque rupture
Doctor Y. Katayama (Wakayama, JP)
Abstract Slides
Presentation thumbnail
Five year outcomes of patients with lipid rich plaque detected three-dimensional Integrated-Backscatter intravascular ultrasound (IB-IVUS) in target lesion after second generation DES implantation
Doctor M. Ohta (Toyoake, JP)
Abstract Slides
Presentation thumbnail
Relationship of thrombus healing to underlying plaque characteristics in ST-segment elevation myocardial infarction: an optical coherence tomography study
Doctor M. Cao (Harbin, CN)
Abstract

Access the full session

Session thumbnail
Poster Session 4 - Invasive Imaging

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Webinar
Multimodality imaging in patients with suspected coronary artery disease: what to do and what to avoid
thumbnail
Congress Presentation
Coronary artery disease
thumbnail
Congress Presentation
Novel PET tracers: paving the way for accessible cardiac PET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources